TABLE 4-1 The Four Functions of the GDF

 

  1. Grant-making to countries and other qualifying recipients.

 

  1. Application review, monitoring, and evaluation, including a monitoring and evaluation process after the grant.

 

  1. Procurement through a contractual partner of the GDF, with shipment to the country’s port of entry.

 

  1. Partner mobilization, for technical support in the application process, conducting monitoring and evaluation, and helping with in-country drug management.

 

SOURCE: World Health Organization (http://www.who.int/gtb/publications/gdf/gdf_factsheets.htm).

the GDF and shipped to countries. At the country level, customs, port clearance, warehousing, and distribution are still handled through the country’s own systems. A recent evaluation of the GDF listed three outstanding achievements of the facility (McKinsey and Company, 2003):

  1. Expanded access to high-quality TB drugs

  2. Facilitation of expanded levels of directly observed treatment (DOTS)

  3. System-level benefits resulting in reduced drug prices

The evaluation notes that the combined approach of pooled financing and commodity procurement has been key for the GDF to meet its goals, particularly in providing incentives for countries to adopt the DOTS strategy and to rationalize the choice of drugs used for treatment. The key to stimulating scaled-up drug production was the ability of the GDF to forecast demand.

Coordinated Informed Buying of HIV/AIDS Drugs

A recent example of pooled procurement is found in Management Sciences for Health’s (MSH) collaboration with the Rockefeller Foundation and key African institutions on the design of a program for Coordinated Informed Buying of HIV/AIDS-related drugs in programs of regional pooled procurement under the auspices of ACAME (an association of francophone West African countries’ central medical stores) and CRHCS (East and Southern Africa Commonwealth Regional Health Community Secretariat). The program will expand beyond HIV/AIDS drugs to a wider selection of drugs on countries’ Essential Drugs Lists if the initial experi-



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement